.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Moodys
Harvard Business School
Fuji
Colorcon
AstraZeneca
Healthtrust
Johnson and Johnson
Daiichi Sankyo

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088771

« Back to Dashboard

NDA 088771 describes DEXAMETHASONE SODIUM PHOSPHATE, which is a drug marketed by Akorn, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Fresenius Kabi Usa, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Sola Barnes Hind, Bausch And Lomb, and Sandoz Inc, and is included in twenty-eight NDAs. It is available from nineteen suppliers. Additional details are available on the DEXAMETHASONE SODIUM PHOSPHATE profile page.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

Summary for 088771

Pharmacology for NDA: 088771

Suppliers and Packaging for NDA: 088771

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OPHTHALMIC, OTIC 088771 ANDA Rebel Distributors Corp 21695-847 21695-847-05 5 mL in 1 BOTTLE, PLASTIC (21695-847-05)
DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OPHTHALMIC, OTIC 088771 ANDA Physicians Total Care, Inc. 54868-3129 54868-3129-0 5 mL in 1 BOTTLE, DISPENSING (54868-3129-0)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMIC, OTICStrengthEQ 0.1% PHOSPHATE
Approval Date:Jan 16, 1985TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Covington
Medtronic
Farmers Insurance
Merck
Chubb
McKesson
US Department of Justice
Teva
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot